2025
Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naïve individuals with Long COVID
Grady C, Bhattacharjee B, Silva J, Jaycox J, Lee L, Silva Monteiro V, Sawano M, Massey D, Caraballo C, Gehlhausen J, Tabachnikova A, Mao T, Lucas C, Peña-Hernandez M, Xu L, Tzeng T, Takahashi T, Herrin J, Güthe D, Akrami A, Assaf G, Davis H, Harris K, McCorkell L, Schulz W, Griffin D, Wei H, Ring A, Guan L, Dela Cruz C, Krumholz H, Iwasaki A. Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naïve individuals with Long COVID. Communications Medicine 2025, 5: 163. PMID: 40346201, PMCID: PMC12064684, DOI: 10.1038/s43856-025-00829-3.Peer-Reviewed Original ResearchSpike protein-specific IgGProtein-specific IgGSelf-antigensImmune response to COVID-19 vaccinationCOVID-19 vaccineAntibody responseResponse to COVID-19 vaccinationT cell expansionSARS-CoV-2-specific antibody responsesAssociated with no improvementLong COVIDAssociated with symptom improvementChest painCirculating cytokinesImmune phenotypeProspective studyImmune featuresTransient improvementPrimary seriesVaccine doseHerpes virusImmune responseSymptom improvementSignificant elevationImpact of COVID-19 vaccination
2024
Is Lipid Metabolism of Value in Cancer Research and Treatment? Part II: Role of Specialized Pro-Resolving Mediators in Inflammation, Infections, and Cancer
Babar M, Nassar A, Nie X, Zhang T, He J, Yeung J, Norris P, Ogura H, Muldoon A, Chen L, Libreros S. Is Lipid Metabolism of Value in Cancer Research and Treatment? Part II: Role of Specialized Pro-Resolving Mediators in Inflammation, Infections, and Cancer. Metabolites 2024, 14: 314. PMID: 38921449, PMCID: PMC11205484, DOI: 10.3390/metabo14060314.Peer-Reviewed Original ResearchResolution of inflammationPro-resolving mediatorsTherapeutic effectOral squamous cell carcinomaT cell responsesSquamous cell carcinomaEicosapentaenoic acid derivativeExcessive neutrophil infiltrationDendritic cell migrationEndogenous lipid mediatorsMetastasis of cancer cellsPro-inflammatory cytokinesSpecialized pro-resolving mediatorsCell carcinomaTumor microenvironmentIschemia-related injuryLung inflammationTumor progressionNeutrophil infiltrationCell debris clearanceCystic fibrosisLung cancerAcute inflammationHerpes virusTherapeutic approaches
2018
Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study
Breier A, Buchanan RW, D'Souza D, Nuechterlein K, Marder S, Dunn W, Preskorn S, Macaluso M, Wurfel B, Maguire G, Kakar R, Highum D, Hoffmeyer D, Coskinas E, Litman R, Vohs JL, Radnovich A, Francis MM, Metzler E, Visco A, Mehdiyoun N, Yang Z, Zhang Y, Yolken RH, Dickerson FB. Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study. Schizophrenia Research 2018, 206: 291-299. PMID: 30478008, DOI: 10.1016/j.schres.2018.11.002.Peer-Reviewed Original ResearchConceptsHSV-1Double-blind efficacy trialHerpes simplex virus 1 (HSV-1) infectionEarly phase schizophreniaSimplex virus 1 infectionVirus-1 infectionPathophysiology of schizophreniaPrimary endpointValacyclovir treatmentNegative subjectsRecent trialsVISTA studyEfficacy trialsLetter-Number Sequencing TestNegative groupPositive groupSevere formHerpes virusPositive symptomsMore impairmentTreatment resultsUS sitesCognitive deficitsNon-activated stateSchizophrenia39.4 A DOUBLE-BLIND TRIAL OF VALACYCLOVIR TO IMPROVE COGNITION IN EARLY PHASE SCHIZOPHRENIA: RESULTS FROM THE VISTA STUDY
Breier A, Dickerson F, Buchanan R, Marder S, Neuchterlein K, D’Souza D, Francis M, Radnovich A, Yolken R, Preskorn S, Macaluso M, Yang Z, Mehdyoun N, Kakar R, Dunn W, Hoffmeyer D, Maguire G. 39.4 A DOUBLE-BLIND TRIAL OF VALACYCLOVIR TO IMPROVE COGNITION IN EARLY PHASE SCHIZOPHRENIA: RESULTS FROM THE VISTA STUDY. Schizophrenia Bulletin 2018, 44: s63-s63. PMCID: PMC5888721, DOI: 10.1093/schbul/sby014.162.Peer-Reviewed Original ResearchEarly phase schizophreniaHSV-1 seropositiveHSV-1Cognitive impairmentNegative subjectsHerpes virusPrevious small clinical trialsDuration of psychosisEfficacy of valacyclovirDouble-blind trialSmall clinical trialsHerpes virus infectionHerpes simplex virus type 1Treatment of schizophreniaSimplex virus type 1Life-long infectionVirus type 1Treatment outcome analysisMemory scoresFull therapeutic potentialPlacebo groupAdjunctive placeboInflammatory markersPrimary outcomeHuman CNS
1999
The chicken B locus is a minimal essential major histocompatibility complex
Kaufman J, Milne S, Göbel T, Walker B, Jacob J, Auffray C, Zoorob R, Beck S. The chicken B locus is a minimal essential major histocompatibility complex. Nature 1999, 401: 923-925. PMID: 10553909, DOI: 10.1038/44856.Peer-Reviewed Original ResearchConceptsChicken major histocompatibility complexMajor histocompatibility complexClass I region genesClass III region genesCo-evolution of genesB locusYears of divergenceMajor histocompatibility complex genesHuman major histocompatibility complexI region genesGenesRegion genesChickenMolecular levelCo-evolutionHistocompatibility complexClass I moleculesMHC5Allograft rejectionHaplotypesI moleculesBirdsHerpes virusMammalsClass II
1981
An unusual and fatal case of disseminated cutaneous herpes simplex Infection in a patient with cutaneous T cell lymphoma (mycosis fungoides)
Goldgeier M, Cohen S, Braverman I, Stenn K. An unusual and fatal case of disseminated cutaneous herpes simplex Infection in a patient with cutaneous T cell lymphoma (mycosis fungoides). Journal Of The American Academy Of Dermatology 1981, 4: 176-180. PMID: 7217388, DOI: 10.1016/s0190-9622(81)70021-5.Peer-Reviewed Original ResearchConceptsHerpes simplex infectionMycosis fungoidesSimplex infectionViral cultureCutaneous herpes simplex virus infectionCutaneous herpes simplex infectionCutaneous T-cell lymphomaHerpes simplex virus infectionPlaque stage mycosis fungoidesSerial antibody titersSimplex virus infectionStage mycosis fungoidesT-cell lymphomaCutaneous ulcersImmunocompromised hostCutaneous ulcerationAntibody titersFatal casesTzanck preparationVesicular lesionsHistologic examinationVirus infectionCell lymphomaSkin lesionsHerpes virus
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply